Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study

BACKGROUND: CALM was a randomized phase 3 trial in patients with Crohn’s disease (CD) that demonstrated improved endoscopic outcomes when treatment was escalated based on cutoffs for inflammatory biomarkers, fecal calprotectin (FC), C-reactive protein (CRP), and CD Activity Index (CDAI) remission vs...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinisch, Walter, Panaccione, Remo, Bossuyt, Peter, Baert, Filip, Armuzzi, Alessandro, Hébuterne, Xavier, Travis, Simon, Danese, Silvio, Sandborn, William J, Schreiber, Stefan, Berg, Sofie, Zhou, Qian, Kligys, Kristina, Neimark, Ezequiel, Suleiman, Ahmed A, D’Haens, Geert, Colombel, Jean-Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500520/
https://www.ncbi.nlm.nih.gov/pubmed/32105310
http://dx.doi.org/10.1093/ibd/izaa025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500520/
https://www.ncbi.nlm.nih.gov/pubmed/32105310
http://dx.doi.org/10.1093/ibd/izaa025

Ejemplares similares